Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial

Thomas Ruhstaller, Anita Giobbie-Hurder, Marco Colleoni, Maj-Britt Jensen, Bent Ejlertsen, Evandro de Azambuja, Patrick Neven, István Láng, Erik Hugger Jakobsen, Laurence Gladieff, Hervé Bonnefoi, Vernon J Harvey, Simon Spazzapan, Carlo Tondini, Lucia Del Mastro, Corinne Veyret, Edda Simoncini, Lorenzo Gianni, Christoph Rochlitz, Elena KralidisKhalil Zaman, Jacek Jassem, Martine Piccart-Gebhart, Angelo Di Leo, Richard D Gelber, Alan S Coates, Aron Goldhirsch, Beat Thürlimann, Meredith M Regan, members of the BIG 1-98 Collaborative Group and the International Breast Cancer Study Group

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences